Market Research Industry Today

Emerging Trends and Innovations for the Mice Model Market | projected to reach USD 2.5 Billion by 2030

Mice Model Market was valued USD 1.43 Billion in 2023 and projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 8.3% during the forecast period of 2023-2030 - published by MarketDigits
Published 28 November 2024

According to a research report "Mice Model Market, by  Material Type (Inbred, Outbred, and Hybrid), by Application (Drug Discovery and Development, Personalized Medicine,  Others), End Use (Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, and CROs & CDMOs) & Region - Global Forecast to 2030.

Mice Model Market was valued USD 1.43 Billion in 2023 and projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 8.3% during the forecast period of 2023-2030.

Download Sample Pages - https://www.marketdigits.com/request/sample/4551

Browse in-depth TOC on Mice Model Market

  • 324 - Tables
  • 56 - Figures
  • 370 - Pages

Market Overview: The Mice Model Market is a critical sector within the biomedical research industry, providing indispensable resources for studying human diseases and advancing medical treatments. Mice models serve as essential tools for understanding the genetic, molecular, and physiological aspects of various diseases, including cancer, diabetes, Alzheimer's, and cardiovascular disorders. With the rise in personalized medicine, there's a growing demand for genetically modified mouse models that mimic human diseases, facilitating the development of targeted therapies. The prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders fuels the need for sophisticated mouse models for disease research and drug development. Growing interest in microbiome research has led to the development of mouse models with specific gut microbiota compositions, allowing for the study of host-microbiome interactions. The use of animals in research, including mice, raises ethical concerns regarding animal welfare and the need for humane treatment. Despite facing challenges such as ethical concerns and reproducibility issues, ongoing innovations and research efforts continue to propel market growth and facilitate groundbreaking discoveries in biomedical science.

Market Dynamics

Drivers:

  • Growing Biotechnology and Pharmaceutical Industry
  • Increasing incidence of Chronic diseases
  • Surge in Drug Testing and Development

Opportunities:

  • Advancements in Genetic Engineering
  • Growing Personalized Medicine Research

North America dominates the market for Mice Model.

North America accounts for the largest revenue share in the global Mice Model Market, with a highly developed research infrastructure, including top-tier academic institutions, research hospitals, and pharmaceutical companies. These institutions have strong funding and access to state-of-the-art technologies, making them prime consumers of mice models for various research purposes. Their demand for high-quality, genetically engineered mouse models drives the market growth in North America. The regulatory environment in North America is conducive to biomedical research and innovation. Advanced research infrastructure, a strong biotechnology and pharmaceutical industry, government support, and a favorable regulatory environment positions North America as the dominant market for mice models.

The pharmaceutical industry in Asia Pacific is experiencing exponential growth, driven by factors such as rising healthcare expenditures, a large patient population, and a growing focus on drug development. Governments across Asia Pacific are actively supporting biomedical research through grants, funding programs, and regulatory incentives. Rapid growth in biomedical research, an expanding pharmaceutical industry, technological advancements, government support, outsourcing opportunities, and strategic collaborations has propelled Asia Pacific to the forefront of the mice model market, overshadowing the dominance of other regions.

Top Key Players covered in the market report:

  • Taconic Biosciences
  • Gubra
  • Charles River Laboratories
  • Cyagen
  • GemPharmatech
  • GenOway
  • Harbour BioMed
  • Inotiv
  • Marshall BioResources
  • Ozgene Pty Ltd
  • Shanghai Model Organisms Center
  • Taconic Biosciences
  • THE JACKSON LABORATORY
  • TransCure bioServices

More for Information - Inquire Now!

Segmentations Analysis of Mice Model Market: -

  • By Material Type
  • By Application
  • By End Use
  • By Region

About us:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

Contact Us: Email: sales@marketdigits.com

Other Industry News

Ready to start publishing

Sign Up today!